Press Release

A USD 2.52 Billion Global Metagenomics Market to Witness a CAGR of Around 18.1% During 2025-30

The Global Metagenomics Market size was valued at around USD 2.52 billion in 2024 and is projected to reach USD 5.82 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 18.1% during the forecast period, i.e., 2025-30, cites MarkNtel Advisors in the recent research report. Many factors such as the increase in the number of cases of infectious diseases, technology developments, and supportive regulatory frameworks are driving the global metagenomics market’s substantial growth. For precision medicine in healthcare, metagenomics enables personalized treatment regimens by analyzing microbial communities within individuals. This method not only makes it easier to identify pathogens but also shows how they relate to different illnesses and human health in general. Additionally, Metagenomics analysis has become more affordable and accessible due to developments in sequencing technologies, which has further fueled market expansion. Furthermore, regulatory organizations are beginning to recognize the value of hastening metagenomics techniques approval processes and encouraging further study and advancement in this area.

Moreover, the market for metagenomics offers enormous potential, especially in the search for microbial solutions that improve human health, agricultural productivity, and environmental sustainability. Healthcare professionals must have a thorough understanding of complex microbial ecosystems particularly when diagnosing and treating infectious diseases. Also, businesses can better monitor microbiological safety because of the increasing use of technology in food safety and quality control.

Furthermore, the market is also shifting toward integrating artificial intelligence (AI) and machine learning into metagenomics analysis. It enhances the ability to examine large datasets and perform predictive evaluations efficiently and accurately. Additionally, the emphasis on multi-omics approaches is opening up new opportunities for innovation and setting up the market for long-term revenue growth. It supports researchers and businesses in investigating the possible uses of metagenomics from improving crop resilience to creating innovative probiotics, further states the research report, “Global Metagenomics Market Analysis, 2025.”

Global Metagenomics Market Segmentation Analysis

Clinical Metagenomics Holds the Largest Market Share

Based on the application, the market is further bifurcated into Environmental, Clinical Metagenomics, Drug discovery, Biotechnology, Food & Nutrition, and others. Clinical metagenomics has the largest market share accounting for nearly 35% of the total, due to its critical role in the healthcare industry for diagnosis and treatment. This approach allows a detailed analysis of the microbial communities present in clinical samples to identify pathogens. Clinical metagenomics provides rapid and accurate information about how the microbiome affects health and illness which is crucial for personalized treatment. Furthermore, with the advancements in sequencing technologies and data analysis tools, metagenomics approaches are more accessible and reasonably priced for clinical applications. Clinical metagenomics is expected to become more and more necessary as healthcare continues to advance toward accuracy and efficiency. This solidifies its position as a major player in the global metagenomics industry.

North America Shows Bright Prospects for Metagenomics Industry

North America has around 40% market share in the metagenomics industry globally, because of its robust research environment and technological advancements. The regions have numerous globally renowned universities, research facilities, and biotechnology businesses, which are ultimately augmenting significant investment and revenue growth. Having access to sequencing technologies and bioinformatics tools that facilitate the quick analysis of complex microbial communities, enhances research capabilities. Furthermore, as infectious diseases become more common and personalized medicine becomes more necessary, metagenomics is becoming more popular in clinical settings. A supportive regulatory environment and substantial funding from the public and private sectors further support metabolism initiatives. Together these factors make North America a significant hub for metagenomics research and development worldwide.

Competitive Landscape

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market companies, including Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Illumina Inc., Perkin Elmer Inc., Symbio Scientific Pvt. ltd., Merck KgaA, Eurofins Scientific, Macrogen Inc., Oxford Nanopore Technology, QIAGEN, Promega Corporation, Infobio, and Others are looking forward to strengthening their market positions.

Key Questions Answered in the Research Report

1. What are the industry’s overall statistics or estimates (Overview, Size- By Value, Forecast Numbers, Segmentation, Shares)?
2. What are the trends influencing the current scenario of the market?
3. What key factors would propel and impede the industry across the globe?
4. How has the industry been evolving in terms of geography & solution adoption?
5. How has the competition been shaping up across the regions?
6. How have buying behavior, customer inclination, and expectations from product manufacturers been evolving during 2020-2030?
7. Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?